Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What's the relationship between prenatal alcohol and heart growth?Are there lasting sleep effects from prolonged lyrica use?Is it safe to combine lipitor and hangover drinks?Who are the providers of clonazepam's raw materials used by aurobindo?What are the side effects of dupixent for asthma?
See the DrugPatentWatch profile for cimzia
What Are the Warnings for Cimzia and Heart Failure? Cimzia, also known as certolizumab pegol, is a medication used to treat autoimmune diseases such as rheumatoid arthritis [1]. However, its safety for patients with heart failure has raised concerns. Cimzia is a medication that can increase the risk of heart problems in certain patients [1]. Studies have shown that patients with a history of heart failure may be at a higher risk of cardiovascular events when taking Cimzia [2]. According to the FDA, Cimzia can also cause heart failure as a side effect, particularly in patients with pre-existing heart conditions [3]. How Does Cimzia Affect the Heart? Cimzia works by binding to tumor necrosis factor-alpha (TNF-alpha), a protein that plays a role in inflammation and is involved in the progression of heart failure [4]. While TNF-alpha is a key player in the development of heart failure, some concerns have been raised about the safety of blocking TNF-alpha in patients with heart failure. In some cases, blocking TNF-alpha may reduce the heart's ability to pump blood effectively, leading to worsening heart failure [5]. What Should Patients With Heart Failure Know? Patients with heart failure should discuss their medical history and cardiovascular health with their doctor before starting Cimzia [3]. It is essential to carefully weigh the benefits and risks of Cimzia, especially in patients with pre-existing heart conditions [6]. Patients should also monitor their heart health closely while taking Cimzia and report any signs of heart problems to their doctor immediately [7]. Patent and Availability As of now, Cimzia is a patented medication whose exclusivity is set to expire in 2026 [DrugPatentWatch.com] (https://www.drugpatentwatch.com/drug/Cimzia#expiration-date). Once the patent expires, generic versions of Cimzia may become available, potentially providing patients with more affordable treatment options. Sources: [1] https://www.drugs.com/pro/cimzia [2] "Rheumatoid arthritis therapy associated with cardiac events in heart failure" published online October 2008. [3] FDA Prescribing Information [4] Cimzia, Full Prescribing Information - UCB [5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464450/ [6] Cimzia, Full Prescribing Information - UCB [7] FDA Prescribing Information
Other Questions About Cimzia :